Blockade of the CD47-SIRPA signaling pathway initiates an adaptive immune response to kill tumor cells

Blockade of the CD47-SIRPα signaling pathway initiates an adaptive immune response to kill tumor cells. Blockade of the CD47-SIRPα signaling axis inhibits the degradation of tumor-derived mtDNA through the activation of NOX2, which, once in the cytoplasm of the DC, is recognized by cGAS, further activating the cGAS-cGAMP-STING signaling pathway to release INF-γ, thus promoting T cells to initiate adaptive immune response and kill tumor cells (schematic generated with figdraw). mtDNA, mitochondrial DNA; DC, dendritic cell; NOX, NADPH oxidase; cGAMP, cyclic GMP-AMP; cGAS, cGAMP synthase; INF, interferon; STING, INF gene stimulating factor
Blockade of the CD47-SIRPA signaling pathway initiates an adaptive immune response to kill tumor cells

Publication

Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review) (2024) Fan Wu, et al. Oncol Lett. 2024 Jun;27(6). Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates CGAS CGAS ncbigene_symbol CGAS 115004
Homo sapiens Primates SIRPa SIRPA ncbigene_symbol SIRPA 140885
Homo sapiens Primates CD47 CD47 ncbigene_symbol CD47 961
Homo sapiens Primates NOX2 NOX2 ncbigene_synonym CYBB 1536
Homo sapiens Primates STING STING ncbigene_synonym STING1 340061

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID